Phase-resolved transcriptomic bottlenecks in peptide cancer vaccine response
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Peptide cancer vaccines can elicit antigen-specific immunity, but peripheral immunogenicity often does not translate into durable tumor control.
Methods
We analyzed transcriptomic profiles across three public human peptide-vaccine cohorts: C1/GSE278476, a MUC1 plus Poly-ICLC PBMC RNA-seq cohort with ordered anti-MUC1 IgG response classes; C2/GSE85698, manufactured dendritic-cell vaccine preparations linked to TARP ELISpot response; and C3/GSE53922, baseline PBMC expression linked to overall survival after personalized peptide vaccination in castration-resistant prostate cancer. Prespecified gene modules were summarized as mean standardized scores and tested with endpoint-appropriate cohort-level models with within-family FDR control.
Results
Baseline immune-readiness was favorable in C1 (beta=0.301, p=0.0072, q=0.093; permutation p=0.0088) and associated with longer survival in C3 (HR=0.662, 95% CI 0.532-0.823, p=0.000206, q=0.00126). Baseline erythroid/inflammatory drag showed the opposite direction in C1 (beta=-0.258, p=0.031, q=0.202; permutation p=0.0324) and was associated with inferior survival in C3 (HR=1.390, 95% CI 1.181-1.636, p=0.0000755, q=0.000982). In C2, lower tolerogenic/myeloid dendritic-cell product-state expression was observed in strong ELISpot responders (8/19 focused genes q<0.05). At C1 week 2, a priming/costimulation/mTOR-AKT module showed an FDR-significant cross-sectional association with response class (permutation p=0.0026), but paired within-person change was not significant.
Conclusions
Public peptide-vaccine transcriptomic data support a phase-linked model in which host readiness, erythroid/inflammatory drag, dendritic-cell product state, and early priming are measurable response-linked layers. These retrospective cohorts do not establish causality, biomarker status, clinical utility, or durable tumor control.
